US court finds Copaxone patent invalid again: Natco Pharma
The Natco stock was trading at Rs 2,187.05, up 5.33 percent, on BSE at 1513 hours.
Jun 19, 2015, 15:34 PM IST
Cipla gets USFDA nod for Lopinavir, Ritonavir oral pellets
The company stock closed at Rs 634.90, down 0.95 per cent, on the BSE.
Jun 03, 2015, 17:06 PM IST
Stempeutics' Stempeucel gets Orphan Drug status in Europe
Shares of Cipla were trading at Rs 669.05 per scrip in the afternoon trade on BSE, up 2.86 percent from its previous close.
Jun 01, 2015, 14:31 PM IST
